Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
Health & Insurance + Font Resize -

Caspian Debt to focus on healthcare segment; sees opportunity in medicine discovery

Yash Ved, Mumbai
Wednesday, September 1, 2021, 08:00 Hrs  [IST]

Caspian Debt, a leading provider of debt funding to start-ups and social enterprises, stated that it will continue to focus on the healthcare segment as it is an important part of impact thesis and sees tremendous opportunity in the medicine discovery for the sector.

The company added that it would continue supporting ventures pursuing advancement in the accessibility of significant preventive and medicinal clinical benefits through improvements in teleconsultation and characteristic-of-care diagnostics, and system expansion in Tier Y and Z geography.

The company added that it has provided loans worth Rs. 90 crore to 16 healthcare companies across India.

“We expect the healthcare sector to continue to focus on Covid response as we gear up for the next waves. In addition, we believe that there will be delayed consequences of pandemic-constrained neglected care in non-communicable diseases. We are expecting to steer blended finance to enterprises innovating products and services in response to pandemics,” stated Avishek Gupta, investment director, Caspian Debt.

Gupta added that Caspian Debt's partnership with the USAID-supported SAMRIDH Healthcare Blended Financing Facility as a financing partner is a huge step forward in its endeavour to increase investments in healthcare ventures who are directly contributing to the Covid response.

Gupta stated, “Caspian Debt and SAMRIDH expect to extend blended financial solutions for organizations focussing on health infrastructure, supply chain management for Covid medications and vaccinations, healthcare worker training, and other community-based activities to battle the Covid pandemic through this coordinated effort. Caspian Debt has, in principle committed up to Rs. 35 crore to SAMRIDH's commercial debt investment pool.”

The company stated that the portfolio companies operate across the preventive and curative spectrum with a focus on eyecare, dentalcare, kidney and diagnostics (preventive & curative) and the ticket size of loans are in the range of Rs.50 lakhs to 15 crore.

“However, as a debt provider we look at companies with established traction. Early stage companies will need equity investments to go through the long gestation period for bringing new medicines to the market. Debt capital for research and development and long gestation of trials and approvals is not appropriate,” added Gupta.

Caspian Debt is a digital corporate lending financial services company that offers custom debt solutions to professionally managed small or mid-market companies and start-ups founded by first-generation entrepreneurs with the ambition to grow the company in a transparent, and sustainable manner. Over the last 7 years, Caspian has disbursed debt over Rs. 2,000 crore to 160 companies, supporting the creation of 51k+ jobs.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |